Krensavage Asset Management, LLC Exelixis, Inc. Transaction History

Krensavage Asset Management, LLC

$169 Million
Q4 2024

A detailed history of Krensavage Asset Management, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Krensavage Asset Management, LLC holds 965,866 shares of EXEL stock, worth $35.7 Million. This represents 19.03% of its overall portfolio holdings.

Number of Shares

965,866

Previous 1,281,612 24.64%

Holding current value

$35.7 Million

Previous $32.2 Million -0.0%

% of portfolio

19.03%

Previous 19.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 18, 2025	SELL	$25.39 - $36.46 $8.02 Million - $11.5 Million	-315,746 Reduced 24.64%	965,866 $32.2 Million
Q3 2024 Nov 14, 2024	SELL	$21.96 - $27.6 $8.69 Million - $10.9 Million	-395,781 Reduced 23.6%	1,281,612 $33.3 Million
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $2.26 Million - $2.64 Million	111,253 Added 7.1%	1,677,393 $37.7 Million
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $6.72 Million - $7.97 Million	-332,939 Reduced 17.53%	1,566,140 $37.2 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $1,386 - $1,737	-72 Reduced -0.0%	1,899,079 $45.6 Million
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $4.47 Million - $5.33 Million	-234,552 Reduced 10.99%	1,899,151 $41.5 Million
Q2 2023 Aug 11, 2023	SELL	$18.17 - $20.48 $39,338 - $44,339	-2,165 Reduced 0.1%	2,133,703 $40.8 Million
Q1 2023 May 15, 2023	SELL	$16.3 - $19.41 $35,387 - $42,139	-2,171 Reduced 0.1%	2,135,868 $41.5 Million
Q4 2022 Feb 15, 2023	BUY	$14.96 - $17.39 $4.74 Million - $5.51 Million	316,564 Added 17.38%	2,138,039 $34.3 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $4.93 Million - $7.01 Million	314,590 Added 20.88%	1,821,475 $28.6 Million
Q2 2022 Aug 16, 2022	SELL	$17.44 - $23.16 $410,206 - $544,746	-23,521 Reduced 1.54%	1,506,885 $31.4 Million
Q1 2022 May 17, 2022	SELL	$17.03 - $22.67 $454,922 - $605,583	-26,713 Reduced 1.72%	1,530,406 $34.7 Million
Q4 2021 Feb 15, 2022	BUY	$15.84 - $21.88 $8.82 Million - $12.2 Million	557,119 Added 55.71%	1,557,119 $28.5 Million
Q3 2021 Nov 16, 2021	BUY	$16.3 - $21.14 $16.3 Million - $21.1 Million	1,000,000 New	1,000,000 $21.1 Million

Others Institutions Holding EXEL

# of Institutions

566

Shares Held

251M

Call Options Held

1.45M

Put Options Held

1.13M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krensavage Asset Management, LLC with notifications on news.

Account

Krensavage Asset Management, LLC Exelixis, Inc. Transaction History